IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $4.27 per share which beat the analyst consensus estimate of $3.96 by 7.83 percent. This is a 17.63 percent increase over earnings of $3.63 per share from the same period last year. The company reported quarterly sales of $1.217 billion which beat the analyst consensus estimate of $1.201 billion by 1.36 percent. This is a 9.69 percent increase over sales of $1.109 billion the same period last year.